Ajanta Pharma (India) Investor Sentiment

AJANTPHARM   2,586  21.20  0.83%   
Under 63% of Ajanta Pharma's investor base is looking to short. The analysis of overall sentiment of trading Ajanta Pharma Limited stock suggests that many investors are alarmed at this time. Ajanta Pharma's investing sentiment shows overall attitude of investors towards Ajanta Pharma Limited.
  
over three months ago at news.google.com         
Ajanta Pharma Ltd soars 1.25, up for fifth straight session - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Ltd gains for third straight session - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Ltd gains for third straight session - Trade Brains
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Limited Is About To Go Ex-Dividend, And It Pays A 1.8 percent Yield - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September...
Google News at Macroaxis
over three months ago at news.google.com         
Despite selling recently, Ajanta Pharma Limited insiders own 53 percent stake and recent decline mig...
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Limiteds Stocks On An Uptrend Are Strong Financials Guiding The Market - Simply Wall S...
Google News at Macroaxis
over three months ago at news.google.com         
Stock Radar 50 percent rally in 6 months This pharma stock gave a breakout from a bullish Flag patte...
Google News at Macroaxis
over six months ago at news.google.com         
Ajanta Pharma Limited Just Recorded A 11 percent EPS Beat Heres What Analysts Are Forecasting Next -...
Google News at Macroaxis
over six months ago at news.google.com         
Some Confidence Is Lacking In Ajanta Pharma Limiteds PE - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Ajanta Pharma extends gains for 9th day, shares surge 6 percent to hit 52-week high on 18 percent Yo...
Google News at Macroaxis
over six months ago at news.google.com         
In spite of recent selling, insiders still have the largest holding in Ajanta Pharma Limited with a ...
Google News at Macroaxis
over six months ago at news.google.com         
Ajanta Pharma Ltd Share Price Today Ajanta Pharma Ltd Stock Price Live NSEBSE, Ajanta Pharma Ltd Lat...
Google News at Macroaxis
over six months ago at news.google.com         
Ajanta Pharma buyback Last day today to buy shares for Rs 285 crore special situation opportunity - ...
Google News at Macroaxis
over six months ago at news.google.com         
Defensive pharma stocks with operating profit margins of more than 85 percent to add to your watchli...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ajanta Pharma that are available to investors today. That information is available publicly through Ajanta media outlets and privately through word of mouth or via Ajanta internal channels. However, regardless of the origin, that massive amount of Ajanta data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ajanta Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ajanta Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ajanta Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ajanta Pharma alpha.

Ajanta Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Stock market update Nifty Pharma index 0.44 percent - MSN
12/16/2024
2
Ajanta Pharma Stock Gains 3.3 percent to Reach Rs 3,018.55 on January 7, 2025 - MarketsMojo
01/06/2025
3
Stock Market Live GIFT Nifty Near 23,400 Ajanta Pharma, Biocon, Container Corp Share Prices In Focus - NDTV Profit
01/30/2025
4
What Ajanta Pharma Limiteds PE Is Not Telling You - Simply Wall St
02/19/2025

Complementary Tools for Ajanta Stock analysis

When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio